American depository receipts of European stocks were 0.4% lower at 139.18 on the Bank of New York Mellon Europe ADR Index on Thursday morning.
Decliners in Continental Europe were led by Zealand Pharma ( ZEAL ), 8.5% lower, followed by Cellectis ( CLLS ), a French genome engineering company, down by 8.3% and Oasmia Pharmaceutical ( OASM ), a Sweden-based pharmaceutical company, 3.8% lower. Grifols ( GRFS ), a manufacturer of biopharmaceuticals, was down by 2.9%.
In the UK, Randgold Resources ( GOLD ),a gold mining company, was 6% lower, telecommunications major BT Group (BT) was down by 4.1% and Nightstar (NITE), a clinical-stage gene therapy company, was 3.8% lower. Lloyds Banking Group (LYG) was down by 3%.
Gainers in Continental Europe were led by Trivago (TRVG), an online hotel search platform operator, 8.5% higher, followed by Credit Suisse (CS), a Swiss financial services company, up by 5.2% and Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, 4.4% higher. Telecom Italia (TI), an Italian telecommunications company, was up by 2.9%.
And, in the UK, BHP Billiton (BBL), a mining company, was 1.2% higher, Carnival (CUK), a cruise vacation company, was up by 1.1% and Fly Leasing (FLY), an aircraft leasing company, was also 1.1% higher. Amarin (AMRN), a biopharmaceutical company, was up by 0.9%.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.